Skip to main content
Top
Published in: Trials 1/2018

Open Access 01-12-2018 | Research

“Yellow-dragon Wonderful-seed Formula” for hyperuricemia in gout patients with dampness-heat pouring downward pattern: a pilot randomized controlled trial

Authors: Xiao Ning Yu, Hai Yan Wu, Yuan Ping Deng, Guang Tong Zhuang, Bang Huan Tan, Yan Zhou Huang, Shi Yun Tang, Xiang Tu, James B Jordan, Sen Zhong

Published in: Trials | Issue 1/2018

Login to get access

Abstract

Background

In Traditional Chinese Medicine (TCM) theories, the typical clinical manifestations of gout are attributed to the “dampness-heat pouring downward.” Therefore, TCM practitioners always consider prescribing the formulae which are believed to clear heat and drain dampness for the management of gout. This clinical trial aims: (1) to determine the hypouricemic effect of “Yellow-dragon Wonderful-seed Formula” (YWF) decoction in gout patients with dampness-heat pouring downward pattern and (2) to determine if gypsum could provide additional significant benefits to YWF.

Methods

A total of 72 hyperuricemic individuals with gout and dampness-heat pouring downward pattern were included with 62 of them completing the trial. Participants were randomly assigned to the YWF group, the YWF + gypsum group, or the allopurinol group. YWF and YWF + gypsum decoctions were orally administered for four weeks. Allopurinol was also orally administered for four weeks as the active control. Serum uric acid (sUA) level was the primary outcome measure. Urine urate level, scores on the SF-36 scale, erythrocyte sedimentation rate (ESR), X ray film, and C reactive protein (CRP) level were the secondary outcome measures.

Results

Compared with the values at week 0, YWF and YWF + gypsum did not significantly decrease the sUA level at each weekend reading. YWF, YWF + gypsum, and allopurinol decreased the urine urate levels and there were significant differences between the YWF group and the YWF + gypsum group. All the changes in the eight structures of SF-36 during the intervention period were not significantly different among the three groups and there was no significant difference in the CRP level among the three groups at each weekend reading.

Conclusions

YWM, which modified on the basis of Two Wonderful Herbs Powder (2WHP), does not show significant hypouricemic effect. There is a possibility that Gypsum Fibrosum may provide additional effects to YWF in decreasing the urine urate levels but cannot add benefits to YWF in other outcome measures.

Trial registration

Chinese Clinical Trial Registry, ChiCTR-TRC-12001933. Registered on 10 February 2012.
Appendix
Available only for authorised users
Literature
1.
go back to reference Roddy E, Doherty M. Epidemiology of gout. Arthritis Res Ther. 2010;12(6):223.CrossRef Roddy E, Doherty M. Epidemiology of gout. Arthritis Res Ther. 2010;12(6):223.CrossRef
2.
go back to reference Roddy E, Choi HK. Epidemiology of gout. Rheum Dis Clin N Am. 2014;40(2):155–75.CrossRef Roddy E, Choi HK. Epidemiology of gout. Rheum Dis Clin N Am. 2014;40(2):155–75.CrossRef
3.
go back to reference Liu R, Han C, Wu D, Xia X, Gu J, Guan H, et al. Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int. 2015;2015:762820.PubMedPubMedCentral Liu R, Han C, Wu D, Xia X, Gu J, Guan H, et al. Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int. 2015;2015:762820.PubMedPubMedCentral
4.
go back to reference Shao JH, Mo BQ, Yu RB, Zhong L, Hua L, Xu YC. Epidemiological study on hyperuricemia and gout in community of Nanjing. Chin J Dis Control Prev. 2003;7(4):305–8. Shao JH, Mo BQ, Yu RB, Zhong L, Hua L, Xu YC. Epidemiological study on hyperuricemia and gout in community of Nanjing. Chin J Dis Control Prev. 2003;7(4):305–8.
5.
go back to reference Sun LY, Niu XB, Li JB, Yu QJ. Analysis of blood uric acid and lipid and their relation to gout in 1215 males in Cangzhou in 2004. Chinese J Med Lab Technol. 2005;6(2):135–7. Sun LY, Niu XB, Li JB, Yu QJ. Analysis of blood uric acid and lipid and their relation to gout in 1215 males in Cangzhou in 2004. Chinese J Med Lab Technol. 2005;6(2):135–7.
6.
go back to reference Lu JJ, Qian L, Min W, et al. Study on the prevalence of hyperuricemia and metabolic syndrome in the senior of Guizhou. Guizhou Med J. 2012;36(2):115–8. Lu JJ, Qian L, Min W, et al. Study on the prevalence of hyperuricemia and metabolic syndrome in the senior of Guizhou. Guizhou Med J. 2012;36(2):115–8.
7.
go back to reference Kong LD, Yang C, Ge F, Wang HD, Guo YS. A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice. J Ethnopharmacol. 2004;93(2–3):325–30.CrossRef Kong LD, Yang C, Ge F, Wang HD, Guo YS. A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice. J Ethnopharmacol. 2004;93(2–3):325–30.CrossRef
8.
go back to reference Li CM. Efficacy observation on 98 subjects with gouty arthritis treated with modified Ermiao Powder. Yunnan J Tradit Chinese Med Mater Med. 2012;33(4):47. Li CM. Efficacy observation on 98 subjects with gouty arthritis treated with modified Ermiao Powder. Yunnan J Tradit Chinese Med Mater Med. 2012;33(4):47.
9.
go back to reference Lv YZ, Hu QH, Xing W, Zhen OY, Kong LD. Effects of Ermiao Pill water extracts on imbalance of urate levels and its related genes and protein levels in hyperuricemic mice. Chinese Tradit Herb Drugs. 2010;41(3):418–23. Lv YZ, Hu QH, Xing W, Zhen OY, Kong LD. Effects of Ermiao Pill water extracts on imbalance of urate levels and its related genes and protein levels in hyperuricemic mice. Chinese Tradit Herb Drugs. 2010;41(3):418–23.
10.
go back to reference Lu JZ, Wu M. Modified Sanmiao Pill in the treatment of 30 patients with gout. Jiangsu J Tradit Chinese Med. 1998;19(11):31. Lu JZ, Wu M. Modified Sanmiao Pill in the treatment of 30 patients with gout. Jiangsu J Tradit Chinese Med. 1998;19(11):31.
11.
go back to reference Wei S, Jue HF. On action mechanism of Sanmiao Pill and Medicinal Cyathula Root for inflammatory reaction of acute gouty arthritis. World Chinese Med. 2013;8(2):189–93. Wei S, Jue HF. On action mechanism of Sanmiao Pill and Medicinal Cyathula Root for inflammatory reaction of acute gouty arthritis. World Chinese Med. 2013;8(2):189–93.
12.
go back to reference Hu QU, Jiao RQ, Wang X, Lv YZ, Kong LD. Simiao pill ameliorates urate underexcretion and renal dysfunction in hyperuricemic mice. J Ethnopharmacol. 2010;128(3):685–92.CrossRef Hu QU, Jiao RQ, Wang X, Lv YZ, Kong LD. Simiao pill ameliorates urate underexcretion and renal dysfunction in hyperuricemic mice. J Ethnopharmacol. 2010;128(3):685–92.CrossRef
13.
go back to reference Wang HJ, Zhang GH, Jun Z, Fan XZ. A clinical study on modified Simiao Powder for acute gouty arthritis and hyperuricemia. J Emerg Tradit Chinese Med. 2009;18(10):1609–10 1626. Wang HJ, Zhang GH, Jun Z, Fan XZ. A clinical study on modified Simiao Powder for acute gouty arthritis and hyperuricemia. J Emerg Tradit Chinese Med. 2009;18(10):1609–10 1626.
14.
go back to reference Qiu R, Shen R, Lin D, Chen Y, Ye H. Treatment of 60 cases of gouty arthritis with modified Simiao Tang. J Tradit Chin Med. 2008;28(2):94–7.CrossRef Qiu R, Shen R, Lin D, Chen Y, Ye H. Treatment of 60 cases of gouty arthritis with modified Simiao Tang. J Tradit Chin Med. 2008;28(2):94–7.CrossRef
15.
go back to reference Zhao F, Guochun L, Yang Y, Shi L, Xu L, Yin L. A network pharmacology approach to determine active ingredients and rationality of herb combinations of modified-Simiaowan for treatment of gout. J Ethnopharmacol. 2015;168:1–16.CrossRef Zhao F, Guochun L, Yang Y, Shi L, Xu L, Yin L. A network pharmacology approach to determine active ingredients and rationality of herb combinations of modified-Simiaowan for treatment of gout. J Ethnopharmacol. 2015;168:1–16.CrossRef
16.
go back to reference Wu JX. Gypsum and Sanmiao decoction for the treatment of acute gouty arthritis in 31 subjects. Jiangsu J Tradit Chinese Med. 2014;5:403. Wu JX. Gypsum and Sanmiao decoction for the treatment of acute gouty arthritis in 31 subjects. Jiangsu J Tradit Chinese Med. 2014;5:403.
17.
go back to reference Yuan Q. Heavy dose of gypsum for the treatment of acute gouty arthritis in 26 subjects. Yunnan J Tradit Chinese Med Mater Med. 2002;23(2):15–6. Yuan Q. Heavy dose of gypsum for the treatment of acute gouty arthritis in 26 subjects. Yunnan J Tradit Chinese Med Mater Med. 2002;23(2):15–6.
18.
go back to reference Schlesinger N. Diagnosis of Gout: Clinical, Laboratory, and Radiologic Findings. Am J Manag Care. 2005;11:S443–50.PubMed Schlesinger N. Diagnosis of Gout: Clinical, Laboratory, and Radiologic Findings. Am J Manag Care. 2005;11:S443–50.PubMed
19.
go back to reference State Administration of Traditional Chinese Medicine of the People’s Republic of China. Criteria of Diagnosis and Therapeutic Effect of Internal Diseases and Syndromes in Traditional Chinese Medicine. ZY/T001.1–94. State Administration of Traditional Chinese Medicine of the People’s Republic of China. Criteria of Diagnosis and Therapeutic Effect of Internal Diseases and Syndromes in Traditional Chinese Medicine. ZY/T001.1–94.
20.
go back to reference Chinese National Committee of Pharmacopeia. Pharmacopeia of People’s Republic of China (2015 Edition). Beijing: China Medical Science Press; 2015. Chinese National Committee of Pharmacopeia. Pharmacopeia of People’s Republic of China (2015 Edition). Beijing: China Medical Science Press; 2015.
22.
go back to reference Borghi C, Perez-Ruiz F. Urate lowering therapies in the treatment of gout: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2016;20(5):983–92.PubMed Borghi C, Perez-Ruiz F. Urate lowering therapies in the treatment of gout: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2016;20(5):983–92.PubMed
25.
28.
go back to reference Sun WF, Zhu MM, Li J, Zhang XX, Liu YW, Wu XR, et al. Effects of Xie-Zhuo-Chu-Bi-Fang on miR-34a and URAT1 and their relationship in hyperuricemic mice. J Ethnopharmacol. 2015;161:163–9.CrossRef Sun WF, Zhu MM, Li J, Zhang XX, Liu YW, Wu XR, et al. Effects of Xie-Zhuo-Chu-Bi-Fang on miR-34a and URAT1 and their relationship in hyperuricemic mice. J Ethnopharmacol. 2015;161:163–9.CrossRef
29.
go back to reference Chen J, Zhou J, Wei S, Xie Z, Wen C, Xu G. Effect of traditional Chinese medicine prescription Quzhuotongbi decoction on hyperuricemia model rats studied by using serum metabolomics based on gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1026:272–8.CrossRef Chen J, Zhou J, Wei S, Xie Z, Wen C, Xu G. Effect of traditional Chinese medicine prescription Quzhuotongbi decoction on hyperuricemia model rats studied by using serum metabolomics based on gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1026:272–8.CrossRef
30.
go back to reference Li XX, Han M, Wang YY, Liu JP. Chinese herbal medicine for gout: a systematic review of randomized clinical trials. Clin Rheumatol. 2013;32(7):943–59.CrossRef Li XX, Han M, Wang YY, Liu JP. Chinese herbal medicine for gout: a systematic review of randomized clinical trials. Clin Rheumatol. 2013;32(7):943–59.CrossRef
31.
go back to reference Tang SY, Wan XM, Qin J, Bo P, Xiang T, Sen Z. Effectiveness of Ermiao San series of prescriptions for gout: a systematic review. Pharmacol Clin Chinese Mater Med. 2014;30(6):198–202. Tang SY, Wan XM, Qin J, Bo P, Xiang T, Sen Z. Effectiveness of Ermiao San series of prescriptions for gout: a systematic review. Pharmacol Clin Chinese Mater Med. 2014;30(6):198–202.
Metadata
Title
“Yellow-dragon Wonderful-seed Formula” for hyperuricemia in gout patients with dampness-heat pouring downward pattern: a pilot randomized controlled trial
Authors
Xiao Ning Yu
Hai Yan Wu
Yuan Ping Deng
Guang Tong Zhuang
Bang Huan Tan
Yan Zhou Huang
Shi Yun Tang
Xiang Tu
James B Jordan
Sen Zhong
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Trials / Issue 1/2018
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-018-2917-8

Other articles of this Issue 1/2018

Trials 1/2018 Go to the issue